Schering-Plough Loses Suit Over Laxative Marketing

Law360, New York (March 4, 2008, 12:00 AM EST) -- A dispute among five drug companies about the marketing of a type of laxative as “prescription only” has resulted in a setback for Schering-Plough Healthcare Products Inc., with a judge denying the company's motion for summary judgment and agreeing to dismiss the case.

The case involves MiraLax, an over-the-counter oral laxative marketed by Schering-Plough. The company had sued four companies that produce a generic, prescription version of the same drug, polyethylene glycol 3350.

Schering-Plough alleged that in marketing their product as “prescription only,” the defendants were...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.